X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
Enter email and you're done. No subscription, no credit card.
Search, tap and you're done. Over 3,400 medicines.
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used mainly for depression, obsessive-compulsive disorder and bulimia. What sets it apart is its extremely long half-life: the drug itself stays in the body for days, its active metabolite norfluoxetine for one to two weeks. That noticeably softens discontinuation symptoms — but it calls for patience and planning whenever anything is changed.
See more detail.gif)
Fluoxetine's interactions follow two patterns: too much serotonin (serotonin syndrome) and altered levels of other medicines via the liver enzyme CYP2D6. On top of that comes the bleeding issue shared by the whole SSRI group.
| Combination | Consequence | What to do |
|---|---|---|
| MAO inhibitors (e.g. tranylcypromine) | Life-threatening serotonin syndrome | The combination is contraindicated; at least 5 weeks' gap after fluoxetine, at least 2 weeks after an MAO inhibitor |
| Tramadol | Increased risk of serotonin syndrome and seizures | Only after medical assessment; know the warning signs, discuss alternatives |
| Triptans such as sumatriptan | Serotonin syndrome possible, if rare | Agree the combination with your doctor; watch for restlessness, muscle twitching, fever |
| NSAIDs such as ibuprofen, aspirin, blood thinners | Clearly increased risk of gastrointestinal bleeding | Do not simply add painkillers; clarify the need and stomach protection with your practice or pharmacy |
| Tamoxifen, metoprolol and other CYP2D6 substrates | Fluoxetine strongly inhibits CYP2D6: tamoxifen can lose effectiveness, metoprolol levels can rise | Have such combinations checked medically — even weeks after fluoxetine has been stopped |
| St John's wort | Serotonin syndrome possible | Herbal does not mean harmless — avoid the combination or declare it |
| Other QT-prolonging medicines (e.g. certain antibiotics, antipsychotics) | Risk of cardiac arrhythmia rises | Show your full medication list; ECG checks may be needed |
| Alcohol | No classic interaction, but stronger drowsiness; alcohol worsens depression | Be cautious, especially at the start |
Two points deserve particular attention. First, painkillers: ibuprofen and other NSAIDs are available without a prescription and seem harmless — but combined with an SSRI, the risk of bleeding in the gastrointestinal tract rises noticeably. Second, the after-effect: because of the long half-life, the precautions apply not only while you are taking fluoxetine but for weeks afterwards. So whenever something new is prescribed, mention that you take fluoxetine or took it recently. Check combinations in the guide to drug interactions or directly in the interaction check in the brite app; on the subject of alcohol, the guide medications and alcohol is worth reading.
All SSRIs inhibit serotonin reuptake and are considered comparably effective according to the guideline.² The differences lie in the pharmacokinetics and the side effect profile — precisely where everyday life happens.
| Active ingredient | Half-life | Character in everyday use |
|---|---|---|
| Fluoxetine | 4–6 days (norfluoxetine 1–2 weeks) | Activating; the mildest discontinuation symptoms in the group, but long waiting times when switching |
| Sertraline | approx. 1 day | Widely used, well studied in heart disease; fairly neutral to slightly activating |
| Citalopram / escitalopram | approx. 1.5 days | Few interactions via liver enzymes, but clear QT-related dose limits |
| Paroxetine | approx. 1 day, no active metabolite | Tends to be sedating; the strongest discontinuation symptoms in the group — the counterpart to fluoxetine |
In practice this means: if lack of drive is the dominant problem, the activating profile of fluoxetine may be an advantage; if you are restless anyway and sleeping badly, another substance may suit you better. Switches to other drug classes such as venlafaxine or mirtazapine also happen — each of these decisions is made by the treating practice on the basis of other conditions, previous medication and tolerability. With every switch away from fluoxetine, the peculiarity from section 6 applies: the old substance is still on board for weeks, so changes run more slowly than with any other SSRI.
Pregnancy: according to Embryotox, the German advisory centre on medicines in pregnancy, fluoxetine is among the best-studied SSRIs in pregnancy and can be continued after medical assessment — untreated depression is also a risk for mother and child.⁴ Important: if a pregnancy is confirmed, do not stop in a panic, but speak to your practice promptly. You will find context and ground rules in the guide medications during pregnancy.
Breastfeeding: here the flip side of the long half-life shows. Fluoxetine and norfluoxetine pass into breast milk and can accumulate in the infant, because their immature liver breaks them down only slowly. Embryotox therefore names other SSRIs as better suited; existing, well-working treatment is not automatically changed, though — that too is an individual medical decision.⁴
Older age: older people react more sensitively to hyponatraemia and bleeding, and interactions pile up with every additional prescription. Regular checks of electrolytes and a complete medication plan are particularly important here — useful groundwork can be found under medications in old age and polypharmacy.
Impaired liver function: fluoxetine is broken down by the liver. If liver function is reduced, the already long half-life gets longer still — the SmPC describes lower or less frequent doses for this situation. That too belongs in medical hands.¹
It is at least well known and common. The side effects — nausea, restlessness, trouble sleeping — usually arrive before the benefit, because the brain has to adapt first. Many people stop precisely in this phase and so deny the medicine the chance to show what it can do. The distinction matters, though: temporary start-up complaints are one thing — growing despair or suicidal thoughts are something else entirely and belong in your practice straight away. When in doubt, it is better to call once too often.
Because fluoxetine is slow twice over: the effect on mood generally takes 2–4 weeks, and the drug level itself only builds up fully over about a month because of the long half-life. An antidepressant is not a painkiller — it does not work within hours. A mood diary kept over several weeks often shows changes earlier than the feeling of individual days can.
With fluoxetine, usually not: the long half-life bridges short gaps better than any other SSRI, and many people do not notice individual missed days at all. Even so, that is no model for the long run — the benefit lives on regularity, and three days quickly turn into a week. A fixed reminder solves the problem more reliably than good intentions.
Please not on your own. First, the guideline recommends continuing treatment for months after things improve, because otherwise the risk of relapse rises considerably.² Second, even a forgiving substance like fluoxetine deserves a planned ending — with agreement, a timetable and an eye on early warning signs. What such an exit looks like is described in the guide stopping SSRIs.
Fluoxetine tends to suppress appetite at first; some people even lose a little weight at the beginning. Over long periods, weight gain is possible as with many antidepressants, but it is less typical than with mirtazapine or paroxetine, for example. Weighing yourself regularly and taking an honest look at eating and exercise says more than any statistic.
The interaction check shows critical combinations before you take them.
